These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


119 related items for PubMed ID: 38685157

  • 21. Cellular, transcriptomic and methylome effects of individual and combined exposure to BPA, BPF, BPS on mouse spermatocyte GC-2 cell line.
    Sidorkiewicz I, Czerniecki J, Jarząbek K, Zbucka-Krętowska M, Wołczyński S.
    Toxicol Appl Pharmacol; 2018 Nov 15; 359():1-11. PubMed ID: 30196065
    [Abstract] [Full Text] [Related]

  • 22. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F, Sakai Y, Eguchi S, Nakashima M, Nakao K.
    PLoS One; 2017 Nov 15; 12(3):e0170591. PubMed ID: 28278289
    [Abstract] [Full Text] [Related]

  • 23. Bisphenol F has different effects on preadipocytes differentiation and weight gain in adult mice as compared with Bisphenol A and S.
    Drobna Z, Talarovicova A, Schrader HE, Fennell TR, Snyder RW, Rissman EF.
    Toxicology; 2019 May 15; 420():66-72. PubMed ID: 30959087
    [Abstract] [Full Text] [Related]

  • 24. Pluripotent Stem Cell-Derived Hepatocytes Phenotypic Screening Reveals Small Molecules Targeting the CDK2/4-C/EBPα/DGAT2 Pathway Preventing ER-Stress Induced Lipid Accumulation.
    Parafati M, Bae SH, Kirby RJ, Fitzek M, Iyer P, Engkvist O, Smith DM, Malany S.
    Int J Mol Sci; 2020 Dec 15; 21(24):. PubMed ID: 33334026
    [Abstract] [Full Text] [Related]

  • 25. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review.
    Cano R, Pérez JL, Dávila LA, Ortega Á, Gómez Y, Valero-Cedeño NJ, Parra H, Manzano A, Véliz Castro TI, Albornoz MPD, Cano G, Rojas-Quintero J, Chacín M, Bermúdez V.
    Int J Mol Sci; 2021 May 01; 22(9):. PubMed ID: 34062716
    [Abstract] [Full Text] [Related]

  • 26. Long-term bisphenol S exposure aggravates non-alcoholic fatty liver by regulating lipid metabolism and inducing endoplasmic reticulum stress response with activation of unfolded protein response in male zebrafish.
    Qin J, Ru S, Wang W, Hao L, Ru Y, Wang J, Zhang X.
    Environ Pollut; 2020 Aug 01; 263(Pt B):114535. PubMed ID: 32283406
    [Abstract] [Full Text] [Related]

  • 27. Bisphenol F and bisphenol S promote lipid accumulation and adipogenesis in human adipose-derived stem cells.
    Reina-Pérez I, Olivas-Martínez A, Mustieles V, Ruiz-Ojeda FJ, Molina-Molina JM, Olea N, Fernández MF.
    Food Chem Toxicol; 2021 Jun 01; 152():112216. PubMed ID: 33865937
    [Abstract] [Full Text] [Related]

  • 28. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
    Zhao T, Wu K, Hogstrand C, Xu YH, Chen GH, Wei CC, Luo Z.
    Cell Mol Life Sci; 2020 May 01; 77(10):1987-2003. PubMed ID: 31392349
    [Abstract] [Full Text] [Related]

  • 29. BPA and its alternatives BPF and BPAF exaggerate hepatic lipid metabolism disorders in male mice fed a high fat diet.
    Sun F, Huang Y, Chen H, Huang J, Zhang L, Wei S, Liu F, Chen D, Huang W.
    Sci Total Environ; 2023 Apr 01; 867():161521. PubMed ID: 36632902
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism.
    Wang D, Lao L, Pang X, Qiao Q, Pang L, Feng Z, Bai F, Sun X, Lin X, Wei J.
    Int Immunopharmacol; 2018 Dec 01; 65():256-267. PubMed ID: 30340105
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study.
    Dallio M, Masarone M, Errico S, Gravina AG, Nicolucci C, Di Sarno R, Gionti L, Tuccillo C, Persico M, Stiuso P, Diano N, Loguercio C, Federico A.
    Aliment Pharmacol Ther; 2018 Mar 01; 47(6):826-837. PubMed ID: 29322544
    [Abstract] [Full Text] [Related]

  • 35. Bisphenol A promotes hepatic lipid deposition involving Kupffer cells M1 polarization in male mice.
    Lv Q, Gao R, Peng C, Yi J, Liu L, Yang S, Li D, Hu J, Luo T, Mei M, Song Y, Wu C, Xiao X, Li Q.
    J Endocrinol; 2017 Aug 01; 234(2):143-154. PubMed ID: 28500084
    [Abstract] [Full Text] [Related]

  • 36. Bisphenol A Exposure May Induce Hepatic Lipid Accumulation via Reprogramming the DNA Methylation Patterns of Genes Involved in Lipid Metabolism.
    Ke ZH, Pan JX, Jin LY, Xu HY, Yu TT, Ullah K, Rahman TU, Ren J, Cheng Y, Dong XY, Sheng JZ, Huang HF.
    Sci Rep; 2016 Aug 09; 6():31331. PubMed ID: 27502578
    [Abstract] [Full Text] [Related]

  • 37. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
    Xu Y, Yang C, Zhang S, Li J, Xiao Q, Huang W.
    Biol Pharm Bull; 2018 Nov 01; 41(11):1638-1644. PubMed ID: 30135326
    [Abstract] [Full Text] [Related]

  • 38. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound.
    Eladak S, Grisin T, Moison D, Guerquin MJ, N'Tumba-Byn T, Pozzi-Gaudin S, Benachi A, Livera G, Rouiller-Fabre V, Habert R.
    Fertil Steril; 2015 Jan 01; 103(1):11-21. PubMed ID: 25475787
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.